| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Cells, Circulating | 60 | 2025 | 949 | 8.420 |
Why?
|
| Epithelial-Mesenchymal Transition | 13 | 2022 | 754 | 2.590 |
Why?
|
| Testicular Hormones | 14 | 2007 | 188 | 2.140 |
Why?
|
| Cell Separation | 21 | 2022 | 1717 | 2.020 |
Why?
|
| Immediate-Early Proteins | 13 | 2021 | 444 | 1.650 |
Why?
|
| Neoplasm Metastasis | 13 | 2022 | 4892 | 1.610 |
Why?
|
| Breast Neoplasms | 36 | 2023 | 21178 | 1.320 |
Why?
|
| Glycoproteins | 14 | 2007 | 2200 | 1.290 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2019 | 699 | 1.200 |
Why?
|
| RNA, Neoplasm | 8 | 2020 | 748 | 1.030 |
Why?
|
| NF-kappa B | 9 | 2024 | 2493 | 0.970 |
Why?
|
| Growth Inhibitors | 7 | 2002 | 375 | 0.890 |
Why?
|
| Gene Expression Regulation, Neoplastic | 26 | 2021 | 8628 | 0.870 |
Why?
|
| Tumor Suppressor Proteins | 11 | 2019 | 2800 | 0.840 |
Why?
|
| Transforming Growth Factor beta | 5 | 2023 | 1995 | 0.830 |
Why?
|
| Microfluidic Analytical Techniques | 14 | 2025 | 789 | 0.820 |
Why?
|
| Cell Line, Tumor | 47 | 2024 | 17097 | 0.790 |
Why?
|
| Cell Cycle | 8 | 2020 | 2927 | 0.770 |
Why?
|
| Mannheimia haemolytica | 7 | 2001 | 11 | 0.750 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2015 | 496 | 0.610 |
Why?
|
| Receptors, Androgen | 6 | 2024 | 1089 | 0.600 |
Why?
|
| Genes, Wilms Tumor | 9 | 1998 | 92 | 0.600 |
Why?
|
| Mitosis | 3 | 2021 | 1176 | 0.590 |
Why?
|
| Prostatic Neoplasms | 17 | 2025 | 11097 | 0.550 |
Why?
|
| Lamin Type B | 1 | 2016 | 28 | 0.550 |
Why?
|
| Drug Resistance, Neoplasm | 13 | 2020 | 5332 | 0.550 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 627 | 0.540 |
Why?
|
| Homeodomain Proteins | 6 | 2018 | 2429 | 0.540 |
Why?
|
| Smad1 Protein | 2 | 2007 | 81 | 0.540 |
Why?
|
| Lung Neoplasms | 15 | 2024 | 13491 | 0.530 |
Why?
|
| Neoplastic Stem Cells | 2 | 2017 | 1349 | 0.510 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2016 | 2952 | 0.510 |
Why?
|
| Zinc Fingers | 7 | 1998 | 577 | 0.510 |
Why?
|
| Microfluidics | 7 | 2025 | 650 | 0.500 |
Why?
|
| Tumor Cells, Cultured | 22 | 2021 | 6106 | 0.500 |
Why?
|
| Anti-Mullerian Hormone | 14 | 2007 | 420 | 0.490 |
Why?
|
| Lab-On-A-Chip Devices | 5 | 2020 | 426 | 0.480 |
Why?
|
| Genomic Instability | 3 | 2021 | 716 | 0.450 |
Why?
|
| Protein Biosynthesis | 2 | 2021 | 2093 | 0.440 |
Why?
|
| Exotoxins | 3 | 2001 | 123 | 0.440 |
Why?
|
| Pancreatic Neoplasms | 8 | 2022 | 5446 | 0.430 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 637 | 0.410 |
Why?
|
| Animals | 72 | 2024 | 168965 | 0.400 |
Why?
|
| Neoplasms | 16 | 2025 | 22350 | 0.400 |
Why?
|
| Neoplasm Proteins | 7 | 2021 | 3599 | 0.370 |
Why?
|
| Gene Expression Regulation | 7 | 2019 | 11923 | 0.360 |
Why?
|
| Cell Proliferation | 10 | 2021 | 10455 | 0.360 |
Why?
|
| Cell Division | 12 | 2005 | 4473 | 0.350 |
Why?
|
| RNA | 3 | 2018 | 2715 | 0.340 |
Why?
|
| DNA-Binding Proteins | 15 | 2011 | 9612 | 0.340 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3611 | 0.330 |
Why?
|
| Humans | 132 | 2025 | 767040 | 0.320 |
Why?
|
| Radiation Tolerance | 1 | 2011 | 476 | 0.320 |
Why?
|
| Signal Transduction | 18 | 2024 | 23621 | 0.310 |
Why?
|
| Tumor Microenvironment | 5 | 2023 | 3944 | 0.310 |
Why?
|
| Mice | 41 | 2024 | 81912 | 0.300 |
Why?
|
| Proteomics | 1 | 2022 | 3913 | 0.300 |
Why?
|
| Sequence Analysis, RNA | 10 | 2020 | 2040 | 0.300 |
Why?
|
| Activins | 3 | 2004 | 211 | 0.300 |
Why?
|
| Bone Neoplasms | 2 | 2018 | 2563 | 0.290 |
Why?
|
| Blood Preservation | 3 | 2017 | 169 | 0.290 |
Why?
|
| Apoptosis | 14 | 2018 | 9513 | 0.290 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 161 | 0.290 |
Why?
|
| Androgens | 2 | 2006 | 1281 | 0.290 |
Why?
|
| Single-Cell Analysis | 9 | 2025 | 2538 | 0.280 |
Why?
|
| Inhibin-beta Subunits | 2 | 2003 | 27 | 0.280 |
Why?
|
| Wilms Tumor | 6 | 2015 | 378 | 0.280 |
Why?
|
| Mice, SCID | 7 | 2022 | 2626 | 0.270 |
Why?
|
| Leukapheresis | 2 | 2025 | 150 | 0.270 |
Why?
|
| DNA, Neoplasm | 5 | 2017 | 1741 | 0.270 |
Why?
|
| Quinazolines | 3 | 2015 | 1369 | 0.260 |
Why?
|
| MicroRNAs | 3 | 2020 | 3792 | 0.260 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2022 | 2061 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2021 | 3608 | 0.260 |
Why?
|
| Estrogen Receptor alpha | 3 | 2021 | 581 | 0.250 |
Why?
|
| Cell Count | 3 | 2022 | 1825 | 0.250 |
Why?
|
| Protein Kinase Inhibitors | 9 | 2023 | 5693 | 0.250 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 420 | 0.250 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2024 | 5389 | 0.240 |
Why?
|
| Cell Survival | 8 | 2021 | 5750 | 0.240 |
Why?
|
| Pasteurellosis, Pneumonic | 4 | 2001 | 4 | 0.240 |
Why?
|
| Transcription Factors | 11 | 2013 | 12158 | 0.230 |
Why?
|
| Cell Movement | 7 | 2021 | 5203 | 0.230 |
Why?
|
| Mice, Inbred NOD | 6 | 2021 | 1837 | 0.230 |
Why?
|
| Cyclin D1 | 1 | 2006 | 453 | 0.230 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 2 | 2021 | 67 | 0.230 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2020 | 1759 | 0.230 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2007 | 1058 | 0.220 |
Why?
|
| Leukocytes | 4 | 2017 | 2034 | 0.220 |
Why?
|
| DNA, Satellite | 2 | 2015 | 67 | 0.220 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2019 | 454 | 0.220 |
Why?
|
| Female | 58 | 2025 | 396660 | 0.220 |
Why?
|
| Radium | 1 | 2024 | 70 | 0.210 |
Why?
|
| Macrophages, Alveolar | 4 | 1999 | 413 | 0.210 |
Why?
|
| DNA Damage | 4 | 2011 | 2469 | 0.210 |
Why?
|
| Complement C3 | 1 | 2005 | 434 | 0.210 |
Why?
|
| Disease Models, Animal | 7 | 2023 | 18330 | 0.210 |
Why?
|
| Estrogen Antagonists | 1 | 2023 | 151 | 0.210 |
Why?
|
| High-Throughput Screening Assays | 2 | 2020 | 940 | 0.210 |
Why?
|
| Epithelial Cells | 5 | 2018 | 3698 | 0.200 |
Why?
|
| Alginates | 2 | 2015 | 248 | 0.200 |
Why?
|
| Disease Progression | 7 | 2023 | 13646 | 0.200 |
Why?
|
| Drug Monitoring | 1 | 2008 | 963 | 0.200 |
Why?
|
| Rhabdomyosarcoma | 2 | 2019 | 358 | 0.190 |
Why?
|
| Receptors, Estrogen | 3 | 2023 | 2252 | 0.190 |
Why?
|
| WT1 Proteins | 10 | 1998 | 183 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 4 | 2021 | 2627 | 0.190 |
Why?
|
| Brain Neoplasms | 2 | 2020 | 9108 | 0.190 |
Why?
|
| BRCA1 Protein | 4 | 2020 | 1155 | 0.190 |
Why?
|
| Cattle Diseases | 1 | 2001 | 50 | 0.190 |
Why?
|
| Mosaicism | 1 | 2024 | 480 | 0.180 |
Why?
|
| Rubidium | 1 | 2000 | 120 | 0.180 |
Why?
|
| Bacterial Toxins | 2 | 1999 | 922 | 0.180 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 58 | 0.180 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2024 | 594 | 0.180 |
Why?
|
| Genes, p53 | 4 | 1997 | 711 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2022 | 2883 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 7 | 2015 | 5796 | 0.170 |
Why?
|
| Blotting, Northern | 7 | 2006 | 1550 | 0.170 |
Why?
|
| RNA, Small Interfering | 5 | 2020 | 3427 | 0.170 |
Why?
|
| Antineoplastic Agents | 10 | 2021 | 13650 | 0.170 |
Why?
|
| Tristetraprolin | 1 | 2020 | 40 | 0.170 |
Why?
|
| Camptothecin | 1 | 2023 | 599 | 0.170 |
Why?
|
| Nanostructures | 2 | 2015 | 549 | 0.170 |
Why?
|
| HMGA2 Protein | 1 | 2020 | 101 | 0.170 |
Why?
|
| Wnt Proteins | 2 | 2015 | 723 | 0.170 |
Why?
|
| RNA, Messenger | 15 | 2017 | 12793 | 0.170 |
Why?
|
| Oscillometry | 1 | 2020 | 151 | 0.170 |
Why?
|
| Transferrin | 1 | 2020 | 283 | 0.170 |
Why?
|
| Antigens | 1 | 2005 | 1442 | 0.160 |
Why?
|
| Cysteine | 1 | 2024 | 896 | 0.160 |
Why?
|
| Mammary Glands, Animal | 1 | 2020 | 273 | 0.160 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 328 | 0.160 |
Why?
|
| Lipogenesis | 1 | 2020 | 217 | 0.160 |
Why?
|
| Methylation | 2 | 2019 | 1076 | 0.160 |
Why?
|
| Adenovirus E1B Proteins | 1 | 1998 | 15 | 0.150 |
Why?
|
| Cytotoxins | 1 | 1999 | 154 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2015 | 1150 | 0.150 |
Why?
|
| Cell Hypoxia | 1 | 2020 | 661 | 0.150 |
Why?
|
| Mutation | 13 | 2024 | 30211 | 0.150 |
Why?
|
| Stereotaxic Techniques | 1 | 2020 | 551 | 0.150 |
Why?
|
| Cell Aggregation | 2 | 2016 | 238 | 0.150 |
Why?
|
| Muscle Neoplasms | 1 | 2019 | 130 | 0.150 |
Why?
|
| Neoplasm Transplantation | 4 | 2020 | 2012 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2021 | 371 | 0.150 |
Why?
|
| Male | 45 | 2025 | 364203 | 0.150 |
Why?
|
| Vitrification | 1 | 2018 | 47 | 0.150 |
Why?
|
| Cell Size | 2 | 2017 | 624 | 0.140 |
Why?
|
| Ribosomal Proteins | 1 | 2020 | 369 | 0.140 |
Why?
|
| Cell Nucleus | 5 | 2013 | 2875 | 0.140 |
Why?
|
| Cattle | 8 | 2001 | 3813 | 0.140 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2020 | 393 | 0.140 |
Why?
|
| Receptors, Peptide | 4 | 2003 | 280 | 0.140 |
Why?
|
| Prolactin | 1 | 2019 | 627 | 0.140 |
Why?
|
| Alternative Splicing | 4 | 2018 | 1103 | 0.140 |
Why?
|
| Genetic Heterogeneity | 2 | 2017 | 735 | 0.140 |
Why?
|
| Stromal Cells | 2 | 2019 | 1335 | 0.130 |
Why?
|
| Lipopolysaccharides | 4 | 1999 | 2217 | 0.130 |
Why?
|
| Melanoma | 4 | 2024 | 5702 | 0.130 |
Why?
|
| Androstenes | 1 | 2018 | 177 | 0.130 |
Why?
|
| beta-Globins | 1 | 2017 | 111 | 0.130 |
Why?
|
| Abdominal Neoplasms | 1 | 2018 | 286 | 0.130 |
Why?
|
| Ficoll | 1 | 2016 | 39 | 0.130 |
Why?
|
| Mice, Nude | 4 | 2022 | 3618 | 0.130 |
Why?
|
| Micromanipulation | 1 | 2016 | 53 | 0.130 |
Why?
|
| Ovary | 1 | 2000 | 965 | 0.130 |
Why?
|
| Immunoconjugates | 1 | 2023 | 975 | 0.130 |
Why?
|
| Neutrophils | 4 | 2017 | 3779 | 0.130 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1998 | 393 | 0.130 |
Why?
|
| Prostate | 2 | 2015 | 1761 | 0.130 |
Why?
|
| Interferon-gamma | 2 | 2003 | 3154 | 0.130 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2007 | 69 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2023 | 11872 | 0.120 |
Why?
|
| Blood Cells | 1 | 2017 | 309 | 0.120 |
Why?
|
| Repressor Proteins | 3 | 2015 | 2979 | 0.120 |
Why?
|
| Phenotype | 4 | 2023 | 16718 | 0.120 |
Why?
|
| Histones | 2 | 2019 | 2597 | 0.120 |
Why?
|
| BRCA2 Protein | 1 | 2020 | 802 | 0.120 |
Why?
|
| Cytokines | 2 | 2001 | 7446 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2018 | 2330 | 0.120 |
Why?
|
| Histone Code | 1 | 2016 | 160 | 0.120 |
Why?
|
| gamma Catenin | 1 | 2014 | 45 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.120 |
Why?
|
| Centromere | 1 | 2015 | 214 | 0.120 |
Why?
|
| Prostate-Specific Antigen | 4 | 2013 | 2463 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2021 | 632 | 0.120 |
Why?
|
| Transcription Factor RelA | 2 | 2007 | 252 | 0.110 |
Why?
|
| Proteins | 4 | 2003 | 6001 | 0.110 |
Why?
|
| Animals, Genetically Modified | 1 | 2019 | 1562 | 0.110 |
Why?
|
| Interleukin-1 | 4 | 2001 | 1252 | 0.110 |
Why?
|
| Recombinant Proteins | 8 | 2007 | 6507 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 4 | 2003 | 304 | 0.110 |
Why?
|
| Phenylthiohydantoin | 1 | 2015 | 206 | 0.110 |
Why?
|
| Brain | 1 | 2020 | 27163 | 0.110 |
Why?
|
| Precancerous Conditions | 2 | 2017 | 980 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2015 | 781 | 0.110 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2017 | 523 | 0.110 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2015 | 283 | 0.110 |
Why?
|
| In Situ Hybridization | 6 | 2010 | 1892 | 0.110 |
Why?
|
| Receptor, erbB-3 | 1 | 2014 | 142 | 0.110 |
Why?
|
| Receptor, erbB-2 | 2 | 2016 | 2599 | 0.110 |
Why?
|
| Mesoderm | 2 | 2013 | 679 | 0.100 |
Why?
|
| Rats | 10 | 2004 | 23713 | 0.100 |
Why?
|
| Blotting, Western | 6 | 2014 | 5022 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2019 | 2509 | 0.100 |
Why?
|
| Capillaries | 1 | 2016 | 755 | 0.100 |
Why?
|
| Phthalazines | 3 | 2020 | 397 | 0.100 |
Why?
|
| S Phase | 2 | 2003 | 424 | 0.100 |
Why?
|
| Genomics | 2 | 2019 | 5924 | 0.100 |
Why?
|
| Blood Platelets | 3 | 2017 | 2464 | 0.100 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2013 | 271 | 0.100 |
Why?
|
| Membrane Proteins | 7 | 2015 | 7868 | 0.100 |
Why?
|
| Breast | 1 | 2001 | 1972 | 0.100 |
Why?
|
| Nuclear Proteins | 4 | 2015 | 5794 | 0.100 |
Why?
|
| Carcinoma, Papillary | 1 | 2017 | 791 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2018 | 1536 | 0.100 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 4357 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2472 | 0.090 |
Why?
|
| Mice, Inbred C3H | 2 | 2003 | 915 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 1889 | 0.090 |
Why?
|
| Biopolymers | 1 | 2012 | 182 | 0.090 |
Why?
|
| Metabolomics | 1 | 2020 | 1675 | 0.090 |
Why?
|
| Transcription, Genetic | 8 | 2013 | 7611 | 0.090 |
Why?
|
| Antigens, Neoplasm | 2 | 2023 | 1997 | 0.090 |
Why?
|
| Phosphorylation | 5 | 2014 | 8310 | 0.090 |
Why?
|
| Introns | 1 | 2013 | 965 | 0.090 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2016 | 539 | 0.090 |
Why?
|
| Erythrocytes | 2 | 2017 | 2411 | 0.090 |
Why?
|
| Cell Tracking | 1 | 2012 | 139 | 0.090 |
Why?
|
| Cell Culture Techniques | 2 | 2015 | 1646 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2020 | 4349 | 0.090 |
Why?
|
| Radiation, Ionizing | 1 | 2011 | 252 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 635 | 0.090 |
Why?
|
| Ligands | 4 | 2024 | 3273 | 0.090 |
Why?
|
| DNA Methylation | 2 | 2023 | 4426 | 0.090 |
Why?
|
| Cell Growth Processes | 2 | 2012 | 380 | 0.090 |
Why?
|
| Indoles | 3 | 2021 | 1836 | 0.090 |
Why?
|
| Kidney Neoplasms | 4 | 2015 | 4282 | 0.090 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 1228 | 0.090 |
Why?
|
| Milk Proteins | 1 | 2010 | 161 | 0.090 |
Why?
|
| Biocompatible Materials | 2 | 2015 | 1690 | 0.090 |
Why?
|
| Anilides | 1 | 2013 | 413 | 0.080 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2012 | 409 | 0.080 |
Why?
|
| Transfection | 8 | 2019 | 5753 | 0.080 |
Why?
|
| Liver Diseases | 1 | 2018 | 1304 | 0.080 |
Why?
|
| Antigens, Surface | 2 | 2011 | 1617 | 0.080 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2009 | 61 | 0.080 |
Why?
|
| Calcium | 2 | 2001 | 5792 | 0.080 |
Why?
|
| Epigenesis, Genetic | 3 | 2023 | 3828 | 0.080 |
Why?
|
| Ovarian Neoplasms | 5 | 2017 | 4903 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 1854 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2020 | 2887 | 0.080 |
Why?
|
| Endothelium, Vascular | 3 | 1999 | 4424 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 1396 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 1604 | 0.080 |
Why?
|
| Up-Regulation | 4 | 2019 | 4143 | 0.080 |
Why?
|
| Cell Line, Transformed | 3 | 2003 | 861 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2020 | 6513 | 0.070 |
Why?
|
| Cell Cycle Proteins | 3 | 2011 | 3440 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 1244 | 0.070 |
Why?
|
| K562 Cells | 2 | 2020 | 644 | 0.070 |
Why?
|
| Piperazines | 4 | 2020 | 2548 | 0.070 |
Why?
|
| Molecular Sequence Data | 11 | 2012 | 17608 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 1626 | 0.070 |
Why?
|
| Zebrafish | 1 | 2019 | 3036 | 0.070 |
Why?
|
| Hep G2 Cells | 2 | 2020 | 378 | 0.070 |
Why?
|
| Chromatin | 3 | 2015 | 2980 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 1998 | 816 | 0.070 |
Why?
|
| RNA, Untranslated | 1 | 2011 | 455 | 0.070 |
Why?
|
| Chemokine CXCL2 | 1 | 2007 | 105 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1752 | 0.070 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2009 | 367 | 0.070 |
Why?
|
| DNA Mutational Analysis | 3 | 2020 | 4114 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2011 | 3587 | 0.070 |
Why?
|
| Interleukin-8 | 2 | 2001 | 704 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 1110 | 0.070 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2014 | 2058 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 1733 | 0.070 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 2 | 2003 | 97 | 0.070 |
Why?
|
| DNA Repair | 2 | 2017 | 2050 | 0.070 |
Why?
|
| Androgen Antagonists | 1 | 2015 | 1412 | 0.070 |
Why?
|
| Activin Receptors, Type I | 2 | 2003 | 133 | 0.070 |
Why?
|
| Base Sequence | 9 | 2010 | 12414 | 0.070 |
Why?
|
| Cell Line | 7 | 2015 | 15567 | 0.070 |
Why?
|
| Middle Aged | 18 | 2024 | 223233 | 0.070 |
Why?
|
| Membrane Glycoproteins | 3 | 2002 | 3702 | 0.070 |
Why?
|
| Receptors, Growth Factor | 2 | 2003 | 324 | 0.060 |
Why?
|
| Osteosarcoma | 5 | 1999 | 910 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1965 | 0.060 |
Why?
|
| Cells, Cultured | 7 | 2020 | 18989 | 0.060 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2008 | 335 | 0.060 |
Why?
|
| Genotype | 4 | 2021 | 13035 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2457 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2008 | 2428 | 0.060 |
Why?
|
| Retinoblastoma-Like Protein p130 | 2 | 2003 | 72 | 0.060 |
Why?
|
| Aged | 14 | 2024 | 171319 | 0.060 |
Why?
|
| COS Cells | 3 | 2003 | 1135 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2007 | 751 | 0.060 |
Why?
|
| Lung | 2 | 2001 | 10076 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 2003 | 2448 | 0.060 |
Why?
|
| Cadherins | 2 | 2022 | 903 | 0.060 |
Why?
|
| Luciferases | 1 | 2006 | 713 | 0.060 |
Why?
|
| Nodal Protein | 1 | 2004 | 36 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2025 | 3667 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2019 | 1244 | 0.060 |
Why?
|
| Ribonucleoproteins | 2 | 1997 | 358 | 0.060 |
Why?
|
| SOXE Transcription Factors | 1 | 2024 | 73 | 0.060 |
Why?
|
| Aged, 80 and over | 9 | 2019 | 59548 | 0.060 |
Why?
|
| Gene Expression | 7 | 2014 | 7587 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 2055 | 0.060 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 2227 | 0.060 |
Why?
|
| Binding Sites | 4 | 2021 | 6014 | 0.060 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2003 | 103 | 0.050 |
Why?
|
| E2F1 Transcription Factor | 1 | 2003 | 182 | 0.050 |
Why?
|
| Smad3 Protein | 1 | 2003 | 166 | 0.050 |
Why?
|
| Inhibins | 1 | 2004 | 210 | 0.050 |
Why?
|
| Retinoblastoma Protein | 2 | 2003 | 670 | 0.050 |
Why?
|
| Biopsy | 3 | 2018 | 6777 | 0.050 |
Why?
|
| E2F Transcription Factors | 1 | 2003 | 270 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2016 | 11657 | 0.050 |
Why?
|
| Neoplastic Processes | 1 | 2022 | 36 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2003 | 317 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2824 | 0.050 |
Why?
|
| Pyrroles | 1 | 2009 | 1122 | 0.050 |
Why?
|
| Quinolines | 1 | 2008 | 770 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 3236 | 0.050 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2003 | 301 | 0.050 |
Why?
|
| Genetic Markers | 1 | 2008 | 2602 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2004 | 8108 | 0.050 |
Why?
|
| Phenylacetates | 1 | 2021 | 112 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2023 | 630 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2009 | 616 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2003 | 705 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2002 | 266 | 0.050 |
Why?
|
| Phospholipases | 1 | 2001 | 75 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2001 | 757 | 0.050 |
Why?
|
| Pyridines | 1 | 2013 | 2890 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4280 | 0.050 |
Why?
|
| Aneuploidy | 1 | 2025 | 573 | 0.050 |
Why?
|
| DNA Primers | 3 | 2001 | 2827 | 0.040 |
Why?
|
| Surface Properties | 2 | 2015 | 1154 | 0.040 |
Why?
|
| Pyrimidines | 2 | 2014 | 3044 | 0.040 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2020 | 43 | 0.040 |
Why?
|
| Cystadenocarcinoma | 1 | 1999 | 54 | 0.040 |
Why?
|
| Amino Acid Sequence | 6 | 1999 | 13411 | 0.040 |
Why?
|
| Neuroblastoma | 1 | 2008 | 1266 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2001 | 411 | 0.040 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2000 | 238 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 3760 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2003 | 1759 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 6360 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2021 | 515 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2001 | 430 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2023 | 562 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2014 | 3461 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 2144 | 0.040 |
Why?
|
| Kidney | 5 | 1998 | 7063 | 0.040 |
Why?
|
| Transcriptional Activation | 2 | 2015 | 1751 | 0.040 |
Why?
|
| Retinoid X Receptors | 1 | 2019 | 91 | 0.040 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2019 | 125 | 0.040 |
Why?
|
| CHO Cells | 1 | 2002 | 1376 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2002 | 855 | 0.040 |
Why?
|
| Lymphoma | 1 | 2008 | 1896 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2014 | 719 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2021 | 582 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2004 | 845 | 0.040 |
Why?
|
| Adult | 11 | 2020 | 223317 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 2212 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 11063 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5859 | 0.040 |
Why?
|
| Cricetinae | 1 | 2002 | 2415 | 0.040 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 1998 | 85 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2024 | 2221 | 0.040 |
Why?
|
| Translocation, Genetic | 2 | 2008 | 1391 | 0.040 |
Why?
|
| Color | 1 | 2019 | 296 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 492 | 0.040 |
Why?
|
| Colorectal Neoplasms | 2 | 2015 | 6966 | 0.040 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2019 | 474 | 0.040 |
Why?
|
| Molecular Probes | 1 | 2019 | 309 | 0.040 |
Why?
|
| Equipment Design | 2 | 2016 | 3489 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1995 | 221 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 549 | 0.030 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 102 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2013 | 777 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2010 | 9551 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2019 | 319 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 2018 | 217 | 0.030 |
Why?
|
| Inclusion Bodies | 1 | 1998 | 277 | 0.030 |
Why?
|
| Cell Transformation, Viral | 1 | 1998 | 527 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 694 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 597 | 0.030 |
Why?
|
| Hardness | 1 | 2016 | 34 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2017 | 199 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2010 | 1608 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2002 | 6067 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2019 | 597 | 0.030 |
Why?
|
| DNA | 2 | 2023 | 7210 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 1885 | 0.030 |
Why?
|
| Epitopes | 1 | 2022 | 2526 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3530 | 0.030 |
Why?
|
| G1 Phase | 1 | 1997 | 403 | 0.030 |
Why?
|
| Microtubules | 1 | 2001 | 1062 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1998 | 2168 | 0.030 |
Why?
|
| Oncogenes | 2 | 2009 | 1232 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2018 | 22254 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 1998 | 571 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 6226 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 1999 | 753 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2850 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2015 | 145 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2015 | 150 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2000 | 1190 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2019 | 1337 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2016 | 210 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2016 | 404 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 872 | 0.030 |
Why?
|
| Osteonectin | 1 | 2014 | 33 | 0.030 |
Why?
|
| Cyclins | 1 | 1997 | 605 | 0.030 |
Why?
|
| Polyamines | 1 | 2015 | 132 | 0.030 |
Why?
|
| Fetus | 3 | 2013 | 1878 | 0.030 |
Why?
|
| Retinal Dehydrogenase | 1 | 2014 | 78 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 1998 | 792 | 0.030 |
Why?
|
| Platelet Activation | 1 | 2017 | 643 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2003 | 2856 | 0.030 |
Why?
|
| RNA Splicing | 2 | 2015 | 903 | 0.030 |
Why?
|
| RNA Interference | 2 | 2014 | 2829 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2015 | 1305 | 0.030 |
Why?
|
| Thromboplastin | 1 | 1996 | 289 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 506 | 0.030 |
Why?
|
| Immunoassay | 1 | 2017 | 744 | 0.030 |
Why?
|
| Gene Amplification | 2 | 2009 | 1088 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 3804 | 0.030 |
Why?
|
| Adenoviridae | 1 | 1998 | 1092 | 0.030 |
Why?
|
| Sulfonamides | 2 | 2014 | 1982 | 0.030 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1995 | 342 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1791 | 0.030 |
Why?
|
| Ribosomal Protein S6 | 1 | 2013 | 70 | 0.030 |
Why?
|
| Hydroxides | 1 | 1993 | 46 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 12536 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2020 | 3093 | 0.030 |
Why?
|
| Hydroxyl Radical | 1 | 1993 | 81 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 518 | 0.030 |
Why?
|
| Neuregulin-1 | 1 | 2014 | 136 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1996 | 911 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1993 | 283 | 0.030 |
Why?
|
| Gelatin | 1 | 2015 | 227 | 0.030 |
Why?
|
| Wnt2 Protein | 1 | 2012 | 29 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 1716 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2015 | 4522 | 0.030 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 9532 | 0.030 |
Why?
|
| Contact Inhibition | 1 | 2012 | 46 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2018 | 727 | 0.030 |
Why?
|
| Insect Proteins | 1 | 2014 | 253 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 1993 | 634 | 0.030 |
Why?
|
| Hepatitis B, Chronic | 1 | 2017 | 413 | 0.030 |
Why?
|
| Dimerization | 1 | 2014 | 882 | 0.030 |
Why?
|
| Adipogenesis | 1 | 2015 | 370 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2024 | 54886 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 255 | 0.020 |
Why?
|
| Biological Specimen Banks | 1 | 2018 | 787 | 0.020 |
Why?
|
| Indazoles | 1 | 2014 | 306 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1999 | 1610 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2023 | 2902 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 826 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1993 | 411 | 0.020 |
Why?
|
| Cell Shape | 1 | 2013 | 372 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 9410 | 0.020 |
Why?
|
| Carbohydrate Sequence | 1 | 2012 | 411 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 1995 | 1494 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 1076 | 0.020 |
Why?
|
| Materials Testing | 1 | 2015 | 870 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2014 | 697 | 0.020 |
Why?
|
| Receptors, Vitronectin | 1 | 2010 | 48 | 0.020 |
Why?
|
| Mullerian Ducts | 2 | 2003 | 203 | 0.020 |
Why?
|
| Acetylation | 1 | 2013 | 1055 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2012 | 252 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2013 | 466 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 1928 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 616 | 0.020 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 557 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 385 | 0.020 |
Why?
|
| Cisplatin | 2 | 2010 | 1656 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 369 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4572 | 0.020 |
Why?
|
| Culture | 1 | 2014 | 622 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2010 | 102 | 0.020 |
Why?
|
| Cell Communication | 1 | 2017 | 1660 | 0.020 |
Why?
|
| Nitriles | 1 | 2015 | 980 | 0.020 |
Why?
|
| Time Factors | 3 | 2018 | 40154 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 904 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 20169 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2017 | 5891 | 0.020 |
Why?
|
| Proteome | 1 | 2020 | 1890 | 0.020 |
Why?
|
| Benzamides | 1 | 2015 | 1376 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 1673 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2015 | 1131 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 1993 | 740 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 1995 | 1148 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2014 | 966 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1407 | 0.020 |
Why?
|
| Neurosecretory Systems | 1 | 2011 | 223 | 0.020 |
Why?
|
| Models, Animal | 1 | 2015 | 2121 | 0.020 |
Why?
|
| Biomedical Engineering | 1 | 2010 | 284 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 712 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2843 | 0.020 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2010 | 168 | 0.020 |
Why?
|
| Swine | 1 | 1999 | 5987 | 0.020 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2009 | 71 | 0.020 |
Why?
|
| Antioxidants | 1 | 2017 | 1671 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 1697 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2011 | 332 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2015 | 2721 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 22361 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2628 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2019 | 4167 | 0.020 |
Why?
|
| Heterochromatin | 1 | 2011 | 294 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1119 | 0.020 |
Why?
|
| Point Mutation | 1 | 1993 | 1591 | 0.020 |
Why?
|
| Temperature | 1 | 2015 | 2232 | 0.020 |
Why?
|
| Mammary Glands, Human | 1 | 2009 | 201 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2017 | 2575 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2012 | 1882 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 384 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2008 | 270 | 0.020 |
Why?
|
| Enzyme Induction | 2 | 1999 | 455 | 0.020 |
Why?
|
| Hemolysin Proteins | 1 | 1967 | 113 | 0.020 |
Why?
|
| Mesothelioma | 1 | 1993 | 774 | 0.020 |
Why?
|
| Computational Biology | 1 | 2019 | 3567 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 1996 | 2140 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2014 | 3621 | 0.020 |
Why?
|
| Staphylococcus | 1 | 1967 | 145 | 0.020 |
Why?
|
| Histone Demethylases | 1 | 2010 | 328 | 0.020 |
Why?
|
| Tetracycline | 2 | 1997 | 216 | 0.020 |
Why?
|
| Early Growth Response Protein 1 | 2 | 1997 | 133 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 1959 | 0.020 |
Why?
|
| Monocytes | 1 | 1996 | 2598 | 0.020 |
Why?
|
| Lymphokines | 1 | 2009 | 924 | 0.020 |
Why?
|
| Polymyxin B | 2 | 1996 | 44 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 2931 | 0.020 |
Why?
|
| Testis | 2 | 1999 | 783 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2019 | 65295 | 0.020 |
Why?
|
| Models, Biological | 1 | 2002 | 9464 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 2011 | 784 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2001 | 1989 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14476 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2008 | 1647 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2012 | 1097 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 2902 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2015 | 4032 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 8940 | 0.010 |
Why?
|
| Prognosis | 2 | 2017 | 29963 | 0.010 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2003 | 70 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 2900 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2014 | 3227 | 0.010 |
Why?
|
| Sex Differentiation | 1 | 2003 | 73 | 0.010 |
Why?
|
| Fibrinolysin | 1 | 2003 | 130 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2018 | 9362 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4780 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3511 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1331 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2015 | 3561 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2008 | 862 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2023 | 81659 | 0.010 |
Why?
|
| Pyridones | 1 | 2008 | 819 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 18063 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13284 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4560 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1995 | 3834 | 0.010 |
Why?
|
| Protein Binding | 1 | 2013 | 9327 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 10092 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2014 | 4925 | 0.010 |
Why?
|
| Antibodies | 1 | 2009 | 2419 | 0.010 |
Why?
|
| Diagnosis | 1 | 2001 | 157 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2008 | 1621 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15424 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 661 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 2003 | 575 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1995 | 4167 | 0.010 |
Why?
|
| Vincristine | 1 | 2001 | 1040 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 2535 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 14098 | 0.010 |
Why?
|
| Ascites | 1 | 1999 | 336 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12823 | 0.010 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 1997 | 69 | 0.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2001 | 617 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 440 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 11217 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 1996 | 108 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 1065 | 0.010 |
Why?
|
| Stem Cells | 1 | 2009 | 3535 | 0.010 |
Why?
|
| RNA-Binding Protein EWS | 1 | 1997 | 211 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1997 | 376 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 39317 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1996 | 53 | 0.010 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1996 | 213 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2001 | 2229 | 0.010 |
Why?
|
| DNA Probes | 1 | 1995 | 541 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20741 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2001 | 1728 | 0.010 |
Why?
|
| Solubility | 1 | 1995 | 1078 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 1430 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1996 | 778 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1993 | 416 | 0.010 |
Why?
|
| Tretinoin | 1 | 1996 | 524 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14672 | 0.010 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1995 | 582 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1995 | 554 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1995 | 1227 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2003 | 2038 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 41718 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1995 | 2677 | 0.010 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1995 | 1137 | 0.000 |
Why?
|
| Kinetics | 1 | 1996 | 6287 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 2 | 1997 | 7469 | 0.000 |
Why?
|
| Immunoelectrophoresis | 1 | 1967 | 94 | 0.000 |
Why?
|
| Immunodiffusion | 1 | 1967 | 141 | 0.000 |
Why?
|
| Chromatography | 1 | 1967 | 189 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1967 | 174 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1967 | 226 | 0.000 |
Why?
|
| Exons | 1 | 1993 | 2391 | 0.000 |
Why?
|
| Immune Sera | 1 | 1967 | 605 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1999 | 5141 | 0.000 |
Why?
|
| Iron | 1 | 1995 | 1811 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 3726 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 10748 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1996 | 4209 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1996 | 4210 | 0.000 |
Why?
|
| Aging | 1 | 2001 | 8729 | 0.000 |
Why?
|
| Rabbits | 1 | 1967 | 4751 | 0.000 |
Why?
|